28.80
-1.40
(-4.64%)
At close: 2:19:54 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in GBP | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 10 | 10 |
Avg. Estimate | 2.5B | 2.72B | 10.82B | 11B |
Low Estimate | 2.49B | 2.71B | 10.68B | 10.74B |
High Estimate | 2.51B | 2.74B | 11.1B | 11.31B |
Year Ago Sales | 2.69B | 2.91B | 11.36B | 10.82B |
Sales Growth (year/est) | -6.94% | -6.47% | -4.77% | 1.66% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0WPA.F | -- | -- | -- | -- |
S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
Downgrade | Barclays: Overweight to Equal-Weight | 2/28/2025 |
Downgrade | Exane BNP Paribas: Outperform to Neutral | 9/20/2023 |
Downgrade | Morgan Stanley: Equal-Weight to Underweight | 5/23/2022 |
Downgrade | B of A Securities: Neutral to Underperform | 1/27/2022 |
Upgrade | Bernstein: Underperform to Market Perform | 11/3/2021 |
Upgrade | Credit Suisse: Underperform to Neutral | 6/25/2021 |